Agios Presents Positive Results from Phase 2 Portion of the

Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition

Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , Texas , Houston , San Diego , California , American , Modupe Idowu , Dan Budwick , Sarah Gheuens , Contactchris Taylor , European Union , Exchange Commission , Nasdaq , Agios Pharmaceuticals Inc , Gut Health , Mcgovern Medical School , American Society Of Hematology , Corporate Communicationsagios Pharmaceuticals , Ut Physicians Comprehensive Sickle Cell Center , Hemoglobin Response Compared , Improvements Observed , Annualized Rates , Sickle Cell Pain Crises , Participants Treated , Ghost Live , Webcast Investor Event , American Society , Annual Meeting , Texas Health Science Center , Comprehensive Sickle Cell Center , Multicenter Study , Patients With Sickle Cell Disease , Presentation Time , Abstract Session , Cell Disease , Sickle Cell Trait , Excluding Thalassemias , Disease Modifying Therapeutics , Sickle Cell Diseaseabstract , Call Informationagios , Substrates Including Hormonal Contraceptives , Prescribing Information , Product Characteristics , Note Regarding Forward Looking Statementsthis , Private Securities Litigation Reform Act , Corporate Communicationsagios , Agios Pharmaceuticals ,